Becton, Dickinson and Company is projected to rise to $195.49 by 2027, a +18% move from its current price of $166.34. BDX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/29/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 31 | $163.58 | $166.38 | $169.23 | +0.02% |
| Aug 1 | $162.47 | $166.42 | $170.46 | +0.05% |
| Aug 2 | $161.63 | $166.46 | $171.43 | +0.07% |
| Aug 3 | $160.93 | $166.50 | $172.25 | +0.09% |
| Aug 4 | $160.33 | $166.53 | $172.98 | +0.12% |
| Aug 5 | $159.78 | $166.57 | $173.65 | +0.14% |
| Aug 6 | $159.29 | $166.61 | $174.27 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $159.29 | $166.61 | $174.27 | +0.16% |
| Week 2 | $156.61 | $166.88 | $177.83 | +0.33% |
| Week 3 | $154.64 | $167.16 | $180.69 | +0.49% |
| Week 4 | $153.04 | $167.43 | $183.17 | +0.65% |
| Week 5 | $151.67 | $167.70 | $185.43 | +0.82% |
| Week 6 | $150.46 | $167.98 | $187.52 | +0.98% |
| Week 7 | $149.39 | $168.25 | $189.49 | +1.15% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BDX is a healthcare company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.
It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments.
Founded in 1897 and headquartered in Franklin Lakes, New Jersey, the company also pursues a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers.
BDX is currently trading at $158.92 per share. Its market cap is $43.79B and it ranks 320.
The near-term forecast for 2026 shows min $140.71, avg $158.92, max $213.94, with ROI 0 and sentiment NEUTRAL.
Looking further out, the forecast suggests a rising path with 2030 avg $236.03 and ROI 48.5%, 2040 avg $601.74 and ROI 278.6%, and 2050 avg $1,101.14 with ROI 592.9%.
A major floor 19.5% below — a decisive break under it would weaken the trend.
The nearest floor, 15.4% below — buyers have tended to step in here.
Resistance now sits 3.9% below — it may act as fresh support.
A major ceiling 3.6% above — clearing it would confirm fresh momentum.
Key BDX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BDX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $154.67 | Buy | $155.60 | Buy |
| MA 10 | $155.08 | Buy | $154.94 | Buy |
| MA 20 | $154.47 | Buy | $153.66 | Buy |
| MA 50 | $149.64 | Buy | $152.05 | Buy |
| MA 100 | $152.79 | Buy | $152.84 | Buy |
| MA 200 | $154.67 | Buy | $154.25 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.05 | Neutral |
| Stoch RSI (14) | 77.28 | Neutral |
| CCI (20) | 130.69 | Buy |
| Williams %R (14) | -10.78 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 5.55 | Buy |
| Bollinger %B (20,2) | 0.91 | Neutral |
| Stochastic %K (14) | 89.22 | Sell |
| TRIX (15) | 0.17 | Buy |
| Awesome (5,34) | 3.38 | Buy |
| Ultimate (7,14,28) | 59.02 | Neutral |
| Momentum (10) | 6.98 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 154.03 | Buy |
| ADX (14) | 11.06 | Neutral |
| ATR (14) | 2.54 | Info |
The 30-day technical picture aligns with a bullish tilt, supported by RSI14 at 60.
Prices are trading above the SMA50 of $149.64 and near the SMA200 of $154.67, indicating a constructive trend for the near term.
Key support sits at $140.71 and resistance at $159.93. The 30-day trading range runs from $142.08 to $177.75.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $140.71 | $166.34 | $223.91 | 0% | Neutral | |
| $160.27 | $195.49 | $249.19 | +18% | Neutral | |
| $176.65 | $219.57 | $287.55 | +32% | Bullish | |
| $183.04 | $231.05 | $309.10 | +39% | Bullish | |
| $192.91 | $246.82 | $336.18 | +48% | Bullish | |
| $218.99 | $283.61 | $392.43 | +71% | Bullish | |
| $237.40 | $310.95 | $436.41 | +87% | Bullish | |
| $275.94 | $365.24 | $519.27 | +120% | Bullish | |
| $308.30 | $412.14 | $592.98 | +148% | Bullish | |
| $302.04 | $407.61 | $593.01 | +145% | Bullish | |
| $447.06 | $629.30 | $959.54 | +278% | Bullish | |
| $763.06 | $1,152.04 | $1,883.16 | +593% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $140.71 | $166.34 | $194.82 | +0.00% |
| August 2026 | $144.58 | $168.66 | $200.57 | +1.39% |
| September 2026 | $144.84 | $169.91 | $203.91 | +0.74% |
| October 2026 | $150.03 | $176.80 | $213.73 | +4.05% |
| November 2026 | $154.60 | $182.86 | $222.38 | +3.43% |
| December 2026 | $154.30 | $183.13 | $223.91 | +0.15% |
Click any year to see its month-by-month BDX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, BDX could reach as high as $223.91, with a base case around $166.34 and support toward $140.71 — roughly 0% from $166.34. A consolidation phase looks the most probable path here.
Expect BDX to range from $160.27 to $249.19 through 2027. The $195.49 average target implies a +18% move from current prices. That is up +18% on the projected 2026 average. Price action looks broadly range-bound.
The BDX price prediction for 2028 points to an average of $219.57 (low $176.65, high $287.55) — a potential gain of +32% on today's $166.34. Buyers look set to stay in control over this stretch.
In 2029, BDX is projected to trade between $183.04 and $309.10, averaging $231.05 — a potential gain of +39% from today's $166.34. That is up +5% on the projected 2028 average. Momentum favours further upside here.
Becton, Dickinson and Company's 2030 outlook centres on $246.82, within a $192.91 to $336.18 range. That is up +7% on the projected 2029 average. That marks a +48% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, BDX could reach as high as $392.43, with a base case around $283.61 and support toward $218.99 — roughly +71% from $166.34. Momentum favours further upside here.
Expect BDX to range from $237.40 to $436.41 through 2032. The $310.95 average target implies a +87% move from current prices. That is up +10% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The BDX price prediction for 2033 points to an average of $365.24 (low $275.94, high $519.27) — a potential gain of +120% on today's $166.34. Momentum favours further upside here.
In 2034, BDX is projected to trade between $308.30 and $592.98, averaging $412.14 — a potential gain of +148% from today's $166.34. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Becton, Dickinson and Company's 2035 outlook centres on $407.61, within a $302.04 to $593.01 range. That is -1% versus the projected 2034 average. That marks a +145% change versus current levels. Momentum favours further upside here.
By 2040, BDX could reach as high as $959.54, with a base case around $629.30 and support toward $447.06 — roughly +278% from $166.34. Buyers look set to stay in control over this stretch.
Expect BDX to range from $763.06 to $1,883.16 through 2050. The $1,152.04 average target implies a +593% move from current prices. That is up +83% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in BDX today (≈ 6.011783 BDX) could be worth
$6,925.84
+$5,925.84 (+593%) by 2050 · US Dollar
Based on the average projected BDX price of $1,152.04 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BDXwould be worth at today's price.
$1,000 invested in BDX on Jul 28, 2025 (≈ 6.953099 BDX) would be worth
$1,156.58
+$156.58 (+15.7%) today · 1.16× · US Dollar
Based on a BDX entry price of $143.82 vs. today's $166.34.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $154.48 | $1,076.77 | +7.7% |
| 1 month ago | $155.92 | $1,066.83 | +6.7% |
| 3 months ago | $149.52 | $1,112.49 | +11.2% |
| 6 months ago | $158.74 | $1,047.86 | +4.8% |
| 1 year ago | $143.82 | $1,156.58 | +15.7% |
| All time (5.0y) ago | $196.45 | $846.73 | -15.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BDX forecast.
Our base-case forecast reaches $330.00 around 2033.
Implied market cap at $330.00: $90.93B
The multi-year forecast points to a sustained upward trajectory across the late 2020s and into the 2030s and beyond. In 2026 the average is $158.92 with ROI 0 and neutral sentiment.
By 2030 the average climbs to $236.03 with ROI 48.5 and bullish sentiment, followed by 2031 at $271.03, 2032 at $297.14, 2033 at $349.42, 2034 at $394.02, and 2035 at $389.28, all with bullish sentiment.
In 2040 the average is $601.74 with ROI 278.6 and bullish sentiment, and by 2050 the average reaches $1,101.14 with ROI 592.9 and bullish sentiment. The forecast also shows higher-end outcomes (for example, 2030 max $321.49, 2040 max $917.53, and 2050 max $1,799.98), illustrating significant potential upside alongside inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows min $184.47, avg $236.03, max $321.49 with ROI 48.5 and sentiment BULLISH.
The outlook turns bullish after 2026, with rising averages and ROIs (e.g., 2027 avg $186.91, 2028 avg $209.80, 2030 avg $236.03 with ROI 48.5, 2040 avg $601.74 with ROI 278.6, and 2050 avg $1,101.14 with ROI 592.9), though near-term parity and inherent market risk remain.
Yes. The 2050 max is $1,799.98 and the 2050 average is $1,101.14, indicating potential to exceed $1,000 in the longer term if the max outcomes occur.
The 2026 min is $140.71, avg is $158.92, max is $213.94, ROI 0, sentiment NEUTRAL.
Becton, Dickinson and Company Community Discussion
0Share your Becton, Dickinson and Company price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.